Donepezil (Aricept) therapy for Alzheimer's disease
Geldmacher, D.S.
Comprehensive Therapy 23(7): 492-493
1997
ISSN/ISBN: 0098-8243 PMID: 9262925 Document Number: 483678
Document emailed within 1 workday
Related Documents
1997: Donepezil (Aricept) for Alzheimer's disease Medical Letter on Drugs and Therapeutics 39(1002): 53-54Robert, P.H.; Gokalsing, E.; Bertogliati, C. 1999: Cholinergic hypothesis and Alzheimer's disease: the place of donepezil (Aricept) L'Encephale 25(Special Issue 5): 23-27; Discussion: 28-29
Rogers, S.L.; Doody, R.S.; Mohs, R.C.; Friedhoff, L.T. 1998: Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group Archives of Internal Medicine 158(9): 1021-1031
Damulin, I.V. 2013: Donepezil in Alzheimer's disease and vascular dementia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7): 71-75
Sánchez Morillo, J.; Demartini Ferrari, A.; Roca de Togores López, A. 2003: Interaction of donepezil and muscular blockers in Alzheimer's disease Revista Espanola de Anestesiologia y Reanimacion 50(2): 97-100
Higashiyama, S.; Kawabe, J.; Hashimoto, H.; Akiyama, H.; Kawamura, E.; Torii, K.; Inoue, K.; Kiriike, N.; Shiomi, S.; Inoue, Y. 2006: 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy Osaka City Medical Journal 52(2): 55-62
Higashiyama, S.; Kawabe, J.; Hashimoto, H.; Akiyama, H.; Kawamura, E.; Torii, K.; Inoue, K.; Kiriike, N.; Shiomi, S.; Inoue, Y. 2006: 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy Osaka City Medical Journal 52(2): 55-62
Creţu, O.; Szalontay, A.S.; Chiriţă, R.; Chiriţă, V. 2008: Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 112(3): 641-645
Henigsberg, N.; Kalember, P.; Hrabać, P.; Rados, M.; Bajs, M.; Rados, M.; Kovavić, Z.; Loncar, M.; Madzar, T. 2011: 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease Collegium Antropologicum 35(Suppl 1): 159-162
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
DE Felice, F.G.; Houzel, J-Christophe.; Garcia-Abreu, Jé.; Louzada, P.Roberto.F.; Afonso, R.C.; Meirelles, M.Nazareth.L.; Lent, R.; Neto, V.Moura.; Ferreira, Sérgio.T. 2001: Inhibition of Alzheimer's disease β-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy FASEB Journal 15(7): 1297-1299
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474
Szpak, G.M.; Lechowicz, W.; Lewandowska, E.; Bertrand, E.; Wierzba-Bobrowicz, T.; Gwiazda, E.; Schmidt-Sidor, B.; Dymecki, J. 2001: Neurones and microglia in central nervous system immune response to degenerative processes. Part 1: Alzheimer's disease and Lewy body variant of Alzheimer's disease. Quantitative study Folia Neuropathologica 39(3): 181-192
Hara, H. 2004: Vaccine therapy for Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 4): 254-258
Asada, T. 2004: Non-pharmacological therapy for Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 72-75
Bufill, E.; Blesa, R. 2006: Alzheimer's disease and brain evolution: is Alzheimer's disease an example of antagonistic pleiotropy? Revista de Neurologia 42(1): 25-33